This case report suggests that Minoxidil may be a potential cause of central serous chorioretinopathy in a 39-year-old cardiologist using it for androgenic alopecia.
April 2024 in “Indian journal of ophthalmology. Case reports”
This study reports a case of acute central serous chorioretinopathy potentially linked to prolonged topical minoxidil use for alopecia, with improvement following cessation of the treatment.
15 citations
,
June 2020 in “Applied Materials Today”
This study found that SA-MS hydrogel released Mo4+ ions which promoted healing of disease-impaired wounds by enhancing cell proliferation and angiogenesis, and through its photothermal effects addressed skin cancer-impaired wounds in mice.
9 citations
,
September 2011 in “Cutaneous and Ocular Toxicology”
This article presents a case of central serous chorioretinopathy occurring after the use of topical minoxidil solution, but reports no clinical study findings.
This study reviews the embryological origins, anatomical and histological structure, and key functions of the skin, emphasizing its protective, sensory, and regulatory roles, as well as the social and psychological impacts of post-lesion changes.